-
C287402-25mgProduct description:CYM-5520 has been used as a sphingosine 1-phosphate receptor 2 (S1pr2) agonist in pancreatic adenocarcinoma cell line (CFPAC-1).Application:CYM-5520 is a specific, noncompetitive allosteric agonist of sphingosine 1-phosphate
-
C287402-50mgProduct description:CYM-5520 has been used as a sphingosine 1-phosphate receptor 2 (S1pr2) agonist in pancreatic adenocarcinoma cell line (CFPAC-1).Application:CYM-5520 is a specific, noncompetitive allosteric agonist of sphingosine 1-phosphate
-
C287402-5mgProduct description:CYM-5520 has been used as a sphingosine 1-phosphate receptor 2 (S1pr2) agonist in pancreatic adenocarcinoma cell line (CFPAC-1).Application:CYM-5520 is a specific, noncompetitive allosteric agonist of sphingosine 1-phosphate
-
C286653-100mgSelective S1P3receptor allosteric agonist.
-
C286653-10mgSelective S1P3receptor allosteric agonist.
-
C286653-50mgSelective S1P3receptor allosteric agonist.
-
C286653-5mgSelective S1P3receptor allosteric agonist.
-
-
-
C412806-25mgInformationCYM-5442 CYM-5442 is a potent and selective S1P 1 agonist with EC50 of 1.35 nM.In vitroCYM-5442 is a chemically optimized version of an original hit (CYM-5181). CYM-5442 interacts with S1P1 in a binding pocket separate from key S1P1
-
-